Biotech firm Actis Biologics said it is looking to raise USD 400 million for its operations in India, the US and Malaysia. “We want to raise USD 250 million to invest in Malaysia, USD 100 million in India and USD 50 million in the US,” Actis Biologics President PN Venugopalan told PTI. The company is in talks with a US-based fund and a UK-based fund to raise USD 250 million for the Malaysian project. “We expect to raise USD 250 million in the next four months for the Malaysian project. Once that is in place, then we will look funds for the Indian and the US operations,” he said. […]